Sansure Biotech Inc. (688289.SH): The human papillomavirus nucleic acid detection kit (PCR-fluorescent probe method) has been approved to increase a variety of expected uses.
Shengxiang Biology (688289.SH) announcement: The company's product, the Human Papillomavirus Nucleic Acid Detection Kit (PCR-Fluorescent...
Sansure Biotech Inc. (688289.SH) announced that the company's human papillomavirus nucleic acid detection kit (PCR-fluorescent probe method) recently received the "Medical Device Change Registration (Filing) Document" issued by the National Medical Products Administration. It has been officially approved for adding cervical cancer primary screening, cervical cancer combined screening, and the expected use of ASCUS population stratification.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


